SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001785982-20-000968
Filing Date
2020-11-13
Accepted
2020-11-13 17:00:32
Documents
49
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q sf0050h_10q.htm 10-Q 631916
2 EXHIBIT 31.1 sf0050h_ex31-1.htm EX-31.1 14034
3 EXHIBIT 32.1 sf0050h_ex32-1.htm EX-32.1 7989
  Complete submission text file 0001785982-20-000968.txt   3778083

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE bixt-20200930.xml EX-101.INS 762988
5 XBRL SCHEMA FILE bixt-20200930.xsd EX-101.SCH 38436
6 XBRL CALCULATION FILE bixt-20200930_cal.xml EX-101.CAL 36447
7 XBRL DEFINITION FILE bixt-20200930_def.xml EX-101.DEF 166463
8 XBRL LABEL FILE bixt-20200930_lab.xml EX-101.LAB 292083
9 XBRL PRESENTATION FILE bixt-20200930_pre.xml EX-101.PRE 231723
Mailing Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464
Business Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464 617-494-1199
BIOXYTRAN, INC (Filer) CIK: 0001445815 (see all company filings)

IRS No.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35027 | Film No.: 201312351
SIC: 2834 Pharmaceutical Preparations